老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

泰和诚医疗

4.65
+0.05001.09%
成交量：6,021.00
成交额：2.80万
市值：2,018.89万
市盈率：-0.89
高：4.84
开：4.65
低：4.52
收：4.60
52周最高：10.77
52周最低：3.80
股本：434.17万
流通股本：140.25万
量比：1.22
换手率：0.43%
股息：- -
股息率：- -
每股收益(TTM):-5.2432
每股收益(LYR):-9.6671
净资产收益率：-29.03%
总资产收益率：-4.48%
市净率：-0.06
市盈率(LYR):-0.48

数据加载中...

总览公司新闻资讯公告
2025/04/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/17

SEC问询函

Form CORRESP - Correspondence
2023/07/14

SEC问询函

Form CORRESP - Correspondence
2023/04/19

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/26

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/30

非美公司披露报告

2018/04/04

非美公司披露报告

更多